Xvivo Perfusion AB (0RKL.LSE) Q2 2025 Earnings

Apr 24Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.38
0.7
1.77
2.85

Details

Expected EPS
0.7480056947520639
Actual EPS
-0.37623262095999993
Surprise EPS
-1.12
Surprise Percent
-150.3%

Description

⁨Xvivo Perfusion AB⁩ (⁦0RKL.LSE⁩) has reported earnings of ⁦-0.37623262095999993⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts